Position in ARWR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,808,706
-$684,120 QoQ
Shares Held
22,190
-44.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#204
of 497 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. ARWR ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,808,706 | 22,190 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,492,826 | 39,758 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,426,023 | 36,542 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,015,178 | 29,434 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $535,430 | 33,888 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $557,311 | 43,745 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $573,306 | 30,495 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $770,034 | 39,754 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $831,757 | 32,003 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,400,256 | 48,960 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,944,721 | 63,553 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,448,749 | 53,917 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,679,122 | 47,087 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,341,170 | 52,802 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $730,039 | 17,999 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $577,581 | 17,476 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $626,456 | 17,792 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $936,310 | 20,359 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,485,915 | 22,412 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,554,444 | 24,899 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $702,230 | 8,479 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $578,223 | 8,720 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $759,089 | 9,893 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $398,993 | 9,266 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $255,209 | 5,909 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||